Novartis AG (LON:0QLR)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 169.44 billion. The enterprise value is 189.27 billion.

Market Cap	169.44B
Enterprise Value	189.27B

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Mar 11, 2025

Share Statistics

Current Share Class	1.96B
Shares Outstanding	n/a
Shares Change (YoY)	-3.32%
Shares Change (QoQ)	-0.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.87B

Valuation Ratios

The trailing PE ratio is 17.00 and the forward PE ratio is 13.49.

PE Ratio	17.00
Forward PE	13.49
PS Ratio	4.21
PB Ratio	5.52
P/TBV Ratio	n/a
P/FCF Ratio	12.01
P/OCF Ratio	11.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.34, with an EV/FCF ratio of 13.42.

EV / Earnings	18.99
EV / Sales	4.65
EV / EBITDA	11.34
EV / EBIT	14.16
EV / FCF	13.42

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.78.

Current Ratio	0.82
Quick Ratio	0.51
Debt / Equity	0.78
Debt / EBITDA	1.44
Debt / FCF	1.69
Interest Coverage	16.54

Financial Efficiency

Return on equity (ROE) is 32.49% and return on invested capital (ROIC) is 15.59%.

Return on Equity (ROE)	32.49%
Return on Assets (ROA)	11.24%
Return on Invested Capital (ROIC)	15.59%
Return on Capital Employed (ROCE)	24.98%
Revenue Per Employee	530,821
Profits Per Employee	131,334
Employee Count	75,883
Asset Turnover	0.55
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 1.44 billion in taxes.

Income Tax	1.44B
Effective Tax Rate	12.62%

Stock Price Statistics

The stock price has decreased by -2.76% in the last 52 weeks. The beta is 0.53, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-2.76%
50-Day Moving Average	94.97
200-Day Moving Average	94.46
Relative Strength Index (RSI)	45.97
Average Volume (20 Days)	337,196

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 40.28 billion and earned 9.97 billion in profits. Earnings per share was 4.99.

Revenue	40.28B
Gross Profit	30.72B
Operating Income	13.25B
Pretax Income	11.39B
Net Income	9.97B
EBITDA	16.44B
EBIT	13.25B
Earnings Per Share (EPS)	4.99

Balance Sheet

The company has 5.11 billion in cash and 23.82 billion in debt, giving a net cash position of -18.71 billion.

Cash & Cash Equivalents	5.11B
Total Debt	23.82B
Net Cash	-18.71B
Net Cash Per Share	n/a
Equity (Book Value)	30.70B
Book Value Per Share	15.73
Working Capital	-4.22B

Cash Flow

In the last 12 months, operating cash flow was 15.17 billion and capital expenditures -1.07 billion, giving a free cash flow of 14.10 billion.

Operating Cash Flow	15.17B
Capital Expenditures	-1.07B
Free Cash Flow	14.10B
FCF Per Share	n/a

Margins

Gross margin is 76.26%, with operating and profit margins of 32.90% and 24.74%.

Gross Margin	76.26%
Operating Margin	32.90%
Pretax Margin	28.28%
Profit Margin	24.74%
EBITDA Margin	40.81%
EBIT Margin	32.90%
FCF Margin	35.02%

Dividends & Yields

This stock pays an annual dividend of 3.07, which amounts to a dividend yield of 3.17%.

Dividend Per Share	3.07
Dividend Yield	3.17%
Dividend Growth (YoY)	4.54%
Years of Dividend Growth	3
Payout Ratio	57.26%
Buyback Yield	3.32%
Shareholder Yield	6.49%
Earnings Yield	5.88%
FCF Yield	8.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6